Paid Clinical Trials in Tamarac, FL
As of September 2026, 72 paid clinical trials are recruiting in Tamarac, Florida. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Tamarac offers studies at sites including Florida Clinical Trials Group for conditions such as Diabetic Foot Ulcers (DFUs), Non-Small Cell Lung Cancer, Advanced Solid Tumors, Anemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Tamarac
Trials by drug in Tamarac
Filter results
Newly added in Tamarac
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
70 clinical trials
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
Top Research Study Locations in Tamarac
Researchers run research studies in Tamarac, FL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Florida Clinical Trials Group | Anemia, Hepatocellular Carcinoma (HCC), Multiple Myeloma (MM) | 5 |
| D&H Tamarac Research Center | Attention-Deficit/Hyperactivity Disorder, Diabetic Kidney Disease (DKD), Severe Alopecia Areata | 4 |
| BRCR Global | Cancer Weight Loss, IO-resistant sqNSCLC, Solid Tumours | 3 |
| BRCR Global - Tamarac | Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Drug-Related Side Effects and Adverse Reactions | 3 |
| BRCR Medical Center Inc. | Advanced Non-Small Cell Lung Cancer, Advanced Solid Tumor, Carcinoma, Non-Small-Cell Lung | 3 |
| Barry University Clinical Research | Diabetic Foot Ulcers (DFUs), Chronic Wound of the Lower Limb (Leg Ulcer or Foot Ulcer), Chronic Wounds | 3 |
| Florida Clinical Trials Group Tamarac | Advanced Gastroesophageal Adenocarcinoma, Advanced Unresectable Gastric Adenocarcinoma, Esophageal Squamous Cell Carcinoma | 3 |
| West Broward Rheumatology Associates, Inc. | Rheumatoid Arthritis, Psoriatic Arthritis | 3 |
| Care Access - Tamarac | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Metabolic Dysfunction-Associated Steatotic Liver Disease | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
| D&H Tamarac Research Center, LLC | Epilepsy, Healthy Volunteer, Type 2 Diabetes | 2 |
| Florida Clinical Trials Group - Tamarac | Advanced Solid Tumors, Endometrial Cancer, MSI-H or dMMR Advanced Solid Tumors | 2 |
| Florida Clinical Trials Group LLC (Tamarac) | Solid Tumors, Adult | 2 |
| Florida Clinical Trials Group. | Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer | 2 |
| GSK Investigational Site | Bronchiectasis, Influenza, Human | 2 |
| MplusM - D&H Tamarac Research Center | Hidradenitis Suppurativa (HS), SARS-CoV-2 | 2 |
| Phoenix Clinical Research | Symptomatic Venous Thromboembolism (VTE), Venous Thromboembolism (VTE) | 2 |
| Anthos Investigative | Atrial Fibrillation (AF) | 2 |
| BRCR Medical Center INC | Solid Tumors, Anemia, Myelodysplastic Syndrome | 2 |
| Research | Severe Asthma, Advanced Solid Tumors | 2 |
| BRCR Medical Center, INC | Breast Cancer | 1 |
| Barry University | Chronic Wounds, Diabetic Foot, Diabetic Foot Ulcers (DFUs) | 1 |
| Boca Raton Clinical Research (BRCR) Global | Melanoma | 1 |
| Clinical Trial Site | Prosthetic-joint Infection | 1 |
| D & H Tamarac Research Center | Diabetic Nephropathies, Minimal Change Disease, Primary Focal Segmental Glomerulosclerosis | 1 |
Active & Upcoming Studies in Tamarac (2026)
Recruiting trials in Tamarac grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (20 active studies)
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. · Phase 2, Phase 3 · Eikon Therapeutics
- A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma · Phase 1 · Shanghai Henlius Biotech
Diabetes & metabolic (3 active studies)
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes · Phase 3 · Novo Nordisk A/S
- Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy · Phase 2 · Endevica Bio
Vaccines (2 active studies)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age · Phase 2 · ModernaTX, Inc.
Neurology & pain (2 active studies)
Cardiovascular (2 active studies)
- A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients · Phase 3 · Colorado Prevention Center
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) · Phase 3 · Anthos Therapeutics, Inc.
Mental health & behavior (1 active study)
Common conditions studied in Tamarac
- Diabetic Foot Ulcers (DFUs) (3 active studies)
- Non-Small Cell Lung Cancer (3 active studies)
- Advanced Solid Tumors (2 active studies)
- Anemia (2 active studies)
- Bronchiectasis (2 active studies)
- Carcinoma, Non-Small-Cell Lung (2 active studies)
Leading research sponsors in Tamarac
- Pfizer
- Eli Lilly and Company
- Regeneron Pharmaceuticals
- Takeda
- Reprise Biomedical, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Tamarac?
There are approximately 72 recruiting clinical trials in Tamarac, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Tamarac pay participants?
Most recruiting trials in Tamarac compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Tamarac?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Tamarac?
The most common conditions under active study in Tamarac include Diabetic Foot Ulcers (DFUs) (3), Non-Small Cell Lung Cancer (3), Advanced Solid Tumors (2), Anemia (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Tamarac?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tamarac on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Tamarac?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Tamarac?
Recruiting research sites in Tamarac include Florida Clinical Trials Group, D&H Tamarac Research Center, BRCR Global, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Tamarac right now?
The largest active categories in Tamarac are Cancer & tumors (20), Diabetes & metabolic (3), Vaccines (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.